Literature DB >> 23061814

Cancer stem cells stemness transcription factors expression correlates with breast cancer disease stage.

Panagiotis Apostolou1, Maria Toloudi, Marina Chatziioannou, Eleni Ioannou, Ioannis Papasotiriou.   

Abstract

Cancer stem cell-like cells (CSCs) are cancer cells that have the ability of self-renewal and differentiation into multiple malignant cell types (hierarchy). Thus, can cause relapses and metastasis. CSCs' phenotype is defined by special transcription factors such as Nanog, Oct3/4, Sox2, Nestin, and CD34. The present study aims to determine the change in gene expression of the above markers in correlation with the stage of the disease in breast cancer patients. Initially, whole blood samples from patients with breast cancer were collected, followed by the isolation and culture of circulating tumor cells (CTCs). This was followed by the quantification of CSCs from the above cultures. CSCs' molecular analysis was performed with qPCR, with the use of gene specific primers. At the same time of the analysis, the clinical assessments of the patients were requested from their physicians. The results indicated a linear relationship between the gene expression of stemness markers and the stage of the disease, as well as specific expression patterns by stage. It seems that these genes have an important role in the progression of the disease, thus they might be target for new treatment approaches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23061814     DOI: 10.2174/157488812804484639

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  16 in total

Review 1.  Epithelial-mesenchymal transition transcription factors and miRNAs: "Plastic surgeons" of breast cancer.

Authors:  Caroline Moyret-Lalle; Emmanuelle Ruiz; Alain Puisieux
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment.

Authors:  Muhammad Zaeem Noman; Yosra Messai; Jane Muret; Meriem Hasmim; Salem Chouaib
Journal:  Cancer Microenviron       Date:  2014-10-22

3.  Changes in BAI1 and nestin expression are prognostic indicators for survival and metastases in breast cancer and provide opportunities for dual targeted therapies.

Authors:  Walter Hans Meisen; Samuel Dubin; Steven T Sizemore; Haritha Mathsyaraja; Katie Thies; Norman L Lehman; Peter Boyer; Alena Cristina Jaime-Ramirez; J Bradley Elder; Kimerly Powell; Arnab Chakravarti; Michael C Ostrowski; Balveen Kaur
Journal:  Mol Cancer Ther       Date:  2014-11-05       Impact factor: 6.261

4.  Circulating tumor cells from melanoma patients show phenotypic plasticity and metastatic potential in xenograft NOD.CB17 mice.

Authors:  Claudia Felici; Francesco Mannavola; Luigia Stefania Stucci; Loren Duda; Paola Cafforio; Camillo Porta; Marco Tucci
Journal:  BMC Cancer       Date:  2022-07-11       Impact factor: 4.638

Review 5.  Nestin involvement in tissue injury and cancer--a potential tumor marker?

Authors:  Ekaterini Christina Tampaki; Lydia Nakopoulou; Athanasios Tampakis; Konstantinos Kontzoglou; Walter P Weber; Gregory Kouraklis
Journal:  Cell Oncol (Dordr)       Date:  2014-08-28       Impact factor: 6.730

Review 6.  Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-11-22       Impact factor: 4.254

7.  Identification of genes involved in breast cancer and breast cancer stem cells.

Authors:  Panagiotis Apostolou; Maria Toloudi; Ioannis Papasotiriou
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-07-15

Review 8.  Nestin as a marker of cancer stem cells.

Authors:  Jakub Neradil; Renata Veselska
Journal:  Cancer Sci       Date:  2015-05-26       Impact factor: 6.716

9.  Gene and isoform expression signatures associated with tumor stage in kidney renal clear cell carcinoma.

Authors:  Qi Liu; Shilin Zhao; Pei-Fang Su; Shyr Yu
Journal:  BMC Syst Biol       Date:  2013-12-09

10.  Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays.

Authors:  Karen Jung; Peng Wang; Nidhi Gupta; Keshav Gopal; Fang Wu; Xiaoxia Ye; Abdulraheem Alshareef; Gilbert Bigras; Todd P McMullen; Bassam S Abdulkarim; Raymond Lai
Journal:  Breast Cancer Res       Date:  2014-11-08       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.